EuroSIDA Study Group
Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations
Laut K, Schmid P, Kuzovatova E, Paduta D, Smidt J, Domingo P, Szlávik J, Lundgren J, Mocroft A, Kirk O, Mulcahy F, Fätkenheuer G, Ristola M, Shepherd L, Gottfredsson M, Sedlacek D, Knysz B, Begovac J, Radoi R, Schmied B, Chkhartishvili N, Florence E, EuroSIDA Study Group. Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations. AIDS 2018
Oct 4, 2018Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations
Oct 4, 2018AIDS 2018
Laut Kamilla Grønborg, Schmid Patrick, Kuzovatova Elena, Paduta Dzmitry, Smidt Jelena, Domingo Pere, Szlávik Janos, Lundgren Jens, Mocroft Amanda, Kirk Ole, Mulcahy Fiona, Fätkenheuer Gerd, Ristola Matti, Shepherd Leah, Gottfredsson Magnus, Sedlacek Dalibor, Knysz Brygida, Begovac Josip, Radoi Roxana, Schmied Brigitte, Chkhartishvili Nikoloz, Florence Eric, EuroSIDA Study Group
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe
Santos J, Gargalianos-Kakolyris P, Schmid P, Hassoun G, Khromova I, Beniowski M, Hadziosmanovic V, Sedlacek D, Paredes R, Lundgren J, Bogner J, Duvivier C, Cozzi-Lepri A, Phillips A, De Wit S, Pedersen C, Reiss P, Blaxhult A, Lazzarin A, Sluzhynska M, Orkin C, EuroSIDA Study Group. Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe. HIV Med 2018; 19:324-338.
Feb 1, 2018Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe
Feb 1, 2018HIV Med 2018; 19:324-338
Santos J R, Gargalianos-Kakolyris P, Schmid Patrick, Hassoun G, Khromova I, Beniowski M, Hadziosmanovic V, Sedlacek D, Paredes R, Lundgren J D, Bogner J, Duvivier C, Cozzi-Lepri A, Phillips A, De Wit S, Pedersen C, Reiss P, Blaxhult A, Lazzarin A, Sluzhynska M, Orkin C, EuroSIDA Study Group
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens
Cozzi-Lepri A, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso M, Lundgren J, Mocroft A, Gottfredsson M, Schmid P, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, EuroSIDA Study Group. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. HIV Med 2017
Oct 6, 2017Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens
Oct 6, 2017HIV Med 2017
Cozzi-Lepri A, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso M H, Lundgren J D, Mocroft A, Gottfredsson M, Schmid Patrick, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, EuroSIDA Study Group
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Phillips A, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J, Vernazza P, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA : the journal of the American Medical Association 2001; 286:2560-7.
Nov 28, 2001HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Nov 28, 2001JAMA : the journal of the American Medical Association 2001; 286:2560-7
Phillips A N, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J D, Vernazza Pietro, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group